🇺🇸 FDA
Patent

US 10576059

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

granted A61KA61K31/40A61P

Quick answer

US patent 10576059 (Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV) held by The United States of America, as Represented by the Secretary, Department of Human Services expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as Represented by the Secretary, Department of Human Services
Grant date
Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/40, A61P, A61P31/18